Funder: METAvivor
Due Dates: March 12, 2025 (Letter of Intent deadline) | August 20, 2025 (Internal submission deadline) | December 30, 2025 (Funding organization's deadline)
Funding Amounts: Up to $200,000 total over two years; includes direct costs (with up to $3,000 for travel) and indirect costs up to 5%.
Summary: Supports early career investigators conducting innovative research on established metastatic breast cancer to improve patient outcomes.
Key Information: Research must focus on established metastases; prevention or diagnostic-only projects are not eligible.